This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 13. Reading the whole list, and the company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market buys they reported, and over which period — the price beside each line, and the measured buy-following figure where there is one. What that costs is on the pricing page.
The most recent filings
5 of 13On an award the register reports a price of 0: nothing was paid, and the Quantity column shows the size.
| Company | Transaction | Reported |
|---|---|---|
| Pharming Group N.V.Chief Legal & Compliance Officer | Option exercisenothing paidquantity 614,000 | Mar 18, 2026 |
| Pharming Group N.V.Chief Legal & Compliance Officer | Option exercisenothing paidquantity 264,087 | Mar 18, 2026 |
| Pharming Group N.V.Chief Compliance and Ethics Officer | Option exercisenothing paidquantity 85,000 | Aug 28, 2025 |
| Pharming Group N.V.Chief Compliance and Ethics Officer | Option exercise€80,750quantity 85,000 | Aug 28, 2025 |
| Pharming Group N.V.Chief Compliance and Ethics Officer | Open-market sell€91,906quantity 78,552 | Aug 28, 2025 |